Skip to main content
FinSpry Logo
FinSpry
VRTX logo
VRTX
(NASDAQ)
Vertex Pharmaceuticals Incorporated
$430.44-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Vertex Pharmaceuticals Incorporated (VRTX) Stock Price & Financial Analysis

Vertex Pharmaceuticals Incorporated Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$427.64 - $439.98
52-Week High$507.92
52-Week Low$362.50
Open$434.31
Volume1.76M
Average Volume (3M)1.16M
Market Cap111.31B
Shares Outstanding256.30M
P/E Ratio (TTM)25.66
Price to Sales (P/S)9.11
Price to Book (P/B)5.75
EV/EBITDA22.15
Revenue (TTM)12.22B
Net Income (TTM)4.34B
Free Cash Flow (TTM)3.19B
EPS (TTM)$16.87
Profit Margin35.51%
Operating Margin37.70%
Return on Equity (ROE)22.41%
Debt to Equity0.20
50-Day MA$446.10
200-Day MA$434.95
52-Week Change-0.96%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Vertex Pharmaceuticals Incorporated

What is the current stock price for VRTX?

As of the latest trading session, VRTX stock trades at $430.44. The 52-week range is $362.50–$507.92, with a day range of $427.64–$439.98.

What is the P/E ratio for VRTX?

Vertex Pharmaceuticals Incorporated's trailing P/E ratio is 25.7, meaning investors pay $25.7 for every $1 of annual earnings. Vertex Pharmaceuticals Incorporated operates in the Healthcare sector.

Does VRTX pay dividends?

Vertex Pharmaceuticals Incorporated does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for VRTX?

Based on 8 analysts, the consensus for VRTX is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of VRTX?

Vertex Pharmaceuticals Incorporated's market capitalization is $110.32B, classifying it as a large-cap company. Vertex Pharmaceuticals Incorporated operates in the Healthcare sector within the Biotechnology industry.